Highlights
NASDAQ: ADXS       Advaxis Inc
Last Price Today's Change   Day's Range   Trading Volume
0.468   -0.036 (7.14%)  0.45 - 0.50  5,978,000

Overview

 
Avg Volume (4 weeks):3,314,750
4 Weeks Range:0.45 - 0.52
4 Weeks Price Volatility (%):
25.71%
52 Weeks Range:0.264 - 1.57
52 Weeks Price Volatility (%):
15.62%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company’s immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4496  5431  869  704 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 PHUN 8.74+7.21 
 MARK 2.17+1.26 
 PROG 2.96+0.46 
 FAMI 0.297-0.023 
 SNAP 55.14-19.97 
 CEI 1.44-0.18 
 CRTD 4.13+1.21 
 PBTS 1.32+0.12 
 DWAC 94.20+48.70 
 INTC 49.46-6.54